Dermata Therapeutics (DRMA) Earnings Date, Estimates & Call Transcripts → How Biden has already won 2024 (From Porter & Company) (Ad) Free DRMA Stock Alerts $0.36 +0.04 (+12.55%) (As of 05/10/2024 ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateMar. 21EstimatedActual EPS (Mar. 21) -$0.21 Missed By -$0.21 Get Dermata Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for DRMA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueDRMA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DRMA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here DRMA Earnings Date and InformationDermata Therapeutics last announced its earnings results on March 21st, 2024. The reported ($0.21) EPS for the quarter. Dermata Therapeutics has generated ($3.65) earnings per share over the last year (($3.65) diluted earnings per share). Read More Dermata Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript3/21/2024Q4 2023-($0.21)($0.21)($0.21)--11/9/2023Q3 2023-($0.54)($0.54)($0.54)--8/10/2023Q2 2023-($0.63)($0.63)($0.63)--5/11/2023Q1 2023-($2.27)($2.27)($2.27)--2/21/2023Q4 2022-($1.92)($1.92)($0.12)--11/10/2022Q3 2022-($3.20)($3.20)($0.20)-- Get the Latest News and Ratings for DRMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/15/2022Q2 2022-($3.84)($3.84)($0.24)--5/16/2022Q1 2022-($5.28)($5.28)($0.33)--9/27/2021Q2 2021-($11.20)($11.20)($0.70)-- Dermata Therapeutics Earnings - Frequently Asked Questions When did Dermata Therapeutics announce their last quarterly earnings? Dermata Therapeutics (NASDAQ:DRMA) last announced its quarterly earning data on Thursday, March 21, 2024. Learn more on DRMA's earnings history. How much profit does Dermata Therapeutics generate each year? Dermata Therapeutics (NASDAQ:DRMA) has a recorded net income of -$7.80 million. DRMA has generated -$3.65 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Salarius Pharmaceuticals Earnings Results CNS Pharmaceuticals Earnings Results CohBar Earnings Results 60 Degrees Pharmaceuticals Earnings Results Sonoma Pharmaceuticals Earnings Results Galmed Pharmaceuticals Earnings Results Bio-Path Earnings Results Notable Labs Earnings Results Clearmind Medicine Earnings Results Avenue Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:DRMA) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldGold Set to EXPLODE!Gold Safe ExchangeUrgent Nvidia WarningAltimetryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dermata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
